Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Canada Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20081
20095
20101
20112
20121
20131
20142
20153
20161
20175
20186
20197
20201
202110
20226
20233
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting12
Terminated10
Active, not recruiting7
Enrolling by invitation6
Not yet recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated9
QED Therapeutics, a BridgeBio company7
ModernaTX, Inc.5
Novartis Pharmaceuticals3
PTC Therapeutics3
BioMarin Pharmaceutical2
Editas Medicine, Inc.2
Forma Therapeutics, Inc.2
Kastle Therapeutics, LLC2
PepGen Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn74
Musculoskeletal Diseases19
Metabolic Diseases15
Hematologic Diseases12
Metabolism, Inborn Errors12
Bone Diseases9
Nervous System Diseases9
Osteochondrodysplasias9
Hemoglobinopathies8
Infant, Newborn, Diseases8

Trials

Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.